Genor Biopharma Holdings Limited's market cap is currently €995.25M. The company's EPS TTM is HK$-1.124; its P/E ratio is ―; Genor Biopharma Holdings Limited is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 0.00	¥ 15.93M	¥ 0.00	¥ 10.33M	¥ 13.04M
Gross Profit	¥ 0.00	¥ 14.95M	¥ 0.00	¥ 7.74M	¥ 3.48M
Operating Income	¥ -711.20M	¥ -786.21M	¥ -859.11M	¥ -924.42M	¥ -514.97M
EBITDA	¥ -551.01M	¥ -675.89M	¥ -819.50M	¥ -2.98B	¥ -480.91M
Net Income	¥ -674.36M	¥ -730.40M	¥ -865.37M	¥ -3.03B	¥ -522.75M
Balance Sheet
Cash & Short-Term Investments	¥ 1.17B	¥ 1.59B	¥ 2.20B	¥ 2.93B	¥ 253.52M
Total Assets	¥ 1.45B	¥ 2.12B	¥ 2.86B	¥ 3.57B	¥ 732.84M
Total Debt	¥ 7.16M	¥ 28.59M	¥ 57.41M	¥ 31.06M	¥ 41.76M
Net Debt	¥ -1.16B	¥ -1.56B	¥ -2.14B	¥ -2.90B	¥ -211.76M
Total Liabilities	¥ 256.18M	¥ 309.87M	¥ 369.73M	¥ 336.32M	¥ 507.38M
Stockholders' Equity	¥ 1.19B	¥ 1.80B	¥ 2.49B	¥ 3.23B	¥ 218.99M
Cash Flow
Free Cash Flow	¥ -426.15M	¥ -590.56M	¥ -695.13M	¥ -885.01M	¥ -138.48M
Operating Cash Flow	¥ -425.12M	¥ -577.61M	¥ -623.74M	¥ -786.72M	¥ -110.53M
Investing Cash Flow	¥ 5.99M	¥ -12.94M	¥ -54.26M	¥ -98.24M	¥ -40.68M
Financing Cash Flow	¥ -6.82M	¥ -57.39M	¥ 17.57M	¥ 3.74B	¥ 278.54M

Currency in CNY

Genor Biopharma Holdings Limited Earnings and Revenue History

Income Statement >

Genor Biopharma Holdings Limited Debt to Assets

Balance Sheet >

Genor Biopharma Holdings Limited Cash Flow

Cash Flow >

Genor Biopharma Holdings Limited Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing